Jadran - Galenski Laboratorij d.d.
Jadran - Galenski Laboratorij d.d., commonly known as JGL, is a prominent pharmaceutical company headquartered in Croatia (HR). Established in 1991, JGL has made significant strides in the healthcare sector, focusing on the development, production, and distribution of innovative pharmaceutical products. The company operates primarily in the European market, with a strong presence in various regions. JGL is renowned for its diverse portfolio, which includes prescription medications, over-the-counter products, and medical devices, particularly in the fields of otorhinolaryngology and dermatology. What sets JGL apart is its commitment to research and development, ensuring high-quality standards and unique formulations that cater to specific health needs. With a solid market position and numerous accolades, JGL continues to be a key player in the pharmaceutical industry, dedicated to improving patient outcomes and advancing healthcare solutions.
DitchCarbon Score
How does Jadran - Galenski Laboratorij d.d.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jadran - Galenski Laboratorij d.d.'s score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jadran - Galenski Laboratorij d.d.'s reported carbon emissions
In 2023, Jadran - Galenski Laboratorij d.d. reported total carbon emissions of approximately 4,202,000 kg CO2e, encompassing both Scope 1 and Scope 2 emissions. This figure represents a significant increase from the previous year's emissions of about 3,445,000 kg CO2e in 2022. The company has also shown an increase from 2,436,000 kg CO2e in 2021. Despite these figures, there are currently no publicly disclosed reduction targets or climate pledges from Jadran - Galenski Laboratorij d.d. This lack of specific commitments may reflect broader industry trends, where many companies are still in the early stages of establishing comprehensive climate strategies. The emissions intensity for Scope 1 and 2 in 2023 was approximately 0.000071 kg CO2e per unit of revenue, indicating a slight decrease from 0.000075 kg CO2e in 2022 and 0.000055 kg CO2e in 2021. As the company continues to navigate its environmental impact, it may benefit from setting clear reduction targets and engaging in climate initiatives to align with global sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | - | - | - |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jadran - Galenski Laboratorij d.d. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
